VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement

VETERANS AFFAIRS, DEPARTMENT OF · VETERANS AFFAIRS, DEPARTMENT OF · 260-NETWORK CONTRACT OFFICE 20 (36C260) is soliciting VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement. Solicitation number 36C26027Q0109. Classified under NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing. Product/service code Q301 — LABORATORY TESTING SERVICES. Place of performance: ID, USA. Responses are due by 19 November 2026 01:00 UTC. Posted on SAM.gov, the US federal contract opportunities system; registration is required to bid.

Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care. 5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon  the Government's needs and discretion. Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN. The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products. The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety.